Karl J Lackner1,2, Davit Manukyan3,4,5, Nadine Müller-Calleja3,4,5. 1. Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, 55131, Mainz, Germany. karl.lackner@unimedizin-mainz.de. 2. Center for Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany. karl.lackner@unimedizin-mainz.de. 3. Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, 55131, Mainz, Germany. 4. Center for Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany. 5. Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
Abstract
PURPOSE OF REVIEW: It is well established that the antiphospholipid syndrome (APS) is caused by antiphospholipid antibodies (aPL). While several underlying mechanisms have been described in the past, many open questions remain. Here, we will review data on endosomal signaling and, in particular, redox signaling in APS. RECENT FINDINGS: Endosomal redox signaling has been implicated in several cellular processes including signaling of proinflammatory cytokines. We have shown that certain aPL can activate endosomal NADPH-oxidase (NOX) in several cell types followed by induction of proinflammatory and procoagulant cellular responses in vitro. Involvement of endosomes in aPL signaling has also been reported by others. In wild-type mice but not in NOX-deficient mice, aPL accelerate venous thrombus formation underscoring the relevance of endosomal NOX. Furthermore, hydroxychloroquine (HCQ) inhibits activation of endosomal NOX and prevents thrombus formation in aPL-treated mice. Endosomal redox signaling is an important novel mechanism involved in APS pathogenesis. This makes endosomes a potential target for future treatment approaches of APS.
PURPOSE OF REVIEW: It is well established that the antiphospholipid syndrome (APS) is caused by antiphospholipid antibodies (aPL). While several underlying mechanisms have been described in the past, many open questions remain. Here, we will review data on endosomal signaling and, in particular, redox signaling in APS. RECENT FINDINGS: Endosomal redox signaling has been implicated in several cellular processes including signaling of proinflammatory cytokines. We have shown that certain aPL can activate endosomal NADPH-oxidase (NOX) in several cell types followed by induction of proinflammatory and procoagulant cellular responses in vitro. Involvement of endosomes in aPL signaling has also been reported by others. In wild-type mice but not in NOX-deficient mice, aPL accelerate venous thrombus formation underscoring the relevance of endosomal NOX. Furthermore, hydroxychloroquine (HCQ) inhibits activation of endosomal NOX and prevents thrombus formation in aPL-treated mice. Endosomal redox signaling is an important novel mechanism involved in APS pathogenesis. This makes endosomes a potential target for future treatment approaches of APS.
Entities:
Keywords:
Antiphospholipid antibodies; Antiphospholipid syndrome; Endosomes; Hydroxychloroquine; NADPH-oxidase; Signal transduction
Authors: Hirotami Matsuo; Julien Chevallier; Nathalie Mayran; Isabelle Le Blanc; Charles Ferguson; Julien Fauré; Nathalie Sartori Blanc; Stefan Matile; Jacques Dubochet; Rémy Sadoul; Robert G Parton; Francis Vilbois; Jean Gruenberg Journal: Science Date: 2004-01-23 Impact factor: 47.728
Authors: S Dunoyer-Geindre; E K Kruithof; B Galve-de Rochemonteix; C Rosnoblet; J Gruenberg; G Reber; P de Moerloose Journal: Thromb Haemost Date: 2001-05 Impact factor: 5.249
Authors: B Galve-de Rochemonteix; T Kobayashi; C Rosnoblet; M Lindsay; R G Parton; G Reber; E de Maistre; D Wahl; E K Kruithof; J Gruenberg; P de Moerloose Journal: Arterioscler Thromb Vasc Biol Date: 2000-02 Impact factor: 8.311
Authors: Qiang Li; Netanya Y Spencer; Fredrick D Oakley; Garry R Buettner; John F Engelhardt Journal: Antioxid Redox Signal Date: 2009-06 Impact factor: 8.401